FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
Approval is based on Phase 3 data showing high rates of skin clearance in patients eligible for systemic treatment or phototherapy.
Approval is based on Phase 3 data showing high rates of skin clearance in patients eligible for systemic treatment or phototherapy.
Research suggests patients using medical weight loss drugs are increasingly seeking treatments for facial volume loss and other appearance changes.
The Clear + Brilliant Touch laser, cleared by the FDA in 2022, includes two wavelengths designed to address wrinkles, pigmentation, and skin texture.
Findings provide insight into the biological mechanisms of picosecond lasers for pigmentation disorders and skin aging, potentially enabling safer parameter selection and clinical application.
Plastic surgeons are calling for a ban on dermal fillers being injected into breasts, warning the procedure carries "unacceptable" risks.